Skip to Content

Enablex Approval History

FDA Approved: Yes (First approved December 22, 2004)
Brand name: Enablex
Generic name: darifenacin
Dosage form: Extended-Release Tablets
Company: Allergan plc
Treatment for: Overactive Bladder

Enablex (darifenacin) is a muscarinic receptor antagonist indicated for the treatment of overactive bladder.

Development History and FDA Approval Process for Enablex

DateArticle
Dec 22, 2004Approval Enablex Novartis Pharmaceuticals Corporation - Treatment for Overactive Bladder

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide